论文部分内容阅读
对某些肾变病综合病征的病例用促肾上腺皮质激素(corticotrophin)或考地松(cortisone)治疗是有价值的(Roscoe 1956)。但很多著者曾着重指出此种疗法所引起的特殊危险,并曾由Luetscher氏等(1953)很好地加以总结。我们这里报告在试用勃雷尼松(Prednisone,考地松的衍生物——译者注)治疗肾变病综合病征时因发生迅速扩散性的蜂窝织炎而致死的两个病例。病例1 男性患者,66岁。在1956年2月因慢性支气管炎和肺气肿的恶化,结果形成充血性心力衰竭。经用卧床休息、毛地黄、汞撒利等药物治疗获得良效。此时患者的尿液经反复检验无蛋白。末一次的汞撒利是在4月间给予的,以后即用醋胺硫二氮唑磺胺acetazolamide 商品名Diamox(一种新利尿剂——译者注)代替。
For some cases of a syndrome of nephrotic syndrome, treatment with corticotrophin or cortisone is of value (Roscoe 1956). However, many authors have highlighted the particular dangers posed by this treatment and have been well summarized by Luetscher et al. (1953). We report here two cases of death from the rapid spread of cellulitis at the time of trial of Prednisone in the treatment of a syndrome of nephrotic syndrome. Case 1 male patient, 66 years old. In February 1956 due to the deterioration of chronic bronchitis and emphysema, the result was congestive heart failure. After bed rest, Foxglove, mercury Sailey and other drug treatment to obtain good effect. At this point the patient’s urine after repeated testing without protein. The last mercury was given in April and was later replaced by diamox, a new diuretic.